Christine Houston
Director/Board Member at St. Louis College of Pharmacy
Christine Houston active positions
Companies | Position | Start | End |
---|---|---|---|
St. Louis College of Pharmacy | Director/Board Member | - | - |
Career history of Christine Houston
Former positions of Christine Houston
Companies | Position | Start | End |
---|---|---|---|
EXPRESS SCRIPTS HOLDING CO | Chief Operating Officer | 31/01/2014 | 23/01/2018 |
Corporate Officer/Principal | 23/01/2018 | 23/01/2018 | |
Multiple Sclerosis Society
Multiple Sclerosis Society Miscellaneous Commercial ServicesCommercial Services The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019. | Corporate Officer/Principal | - | - |
CuraScript, Inc.
CuraScript, Inc. Drugstore ChainsRetail Trade CuraScript provided biopharmaceuticals, complex therapies and related disease treatment services. It offered services for physicians, health plan sponsors, and pharmaceutical manufacturers. The company was founded in 1989 and is headquartered in St. Louis, MO. | Director/Board Member | - | - |
President | - | - | |
Express Scripts, Inc.
Express Scripts, Inc. Drugstore ChainsRetail Trade Express Scripts, Inc. provides pharmacy benefit management services The company was founded by Howard L. Waltman in September 1986 and is headquartered in St. Louis, MO. | Chief Operating Officer | - | - |
Corporate Officer/Principal | - | - |
Training of Christine Houston
St. Louis University | Undergraduate Degree |
Statistics
International
United States | 5 |
Spain | 2 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Director/Board Member | 2 |
Sectoral
Retail Trade | 3 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Express Scripts, Inc.
Express Scripts, Inc. Drugstore ChainsRetail Trade Express Scripts, Inc. provides pharmacy benefit management services The company was founded by Howard L. Waltman in September 1986 and is headquartered in St. Louis, MO. | Retail Trade |
Express Scripts Holding Co.
Express Scripts Holding Co. Insurance Brokers/ServicesFinance Express Scripts Holding Co. operates as a pharmacy benefit management company. It offers opioid management; digital health formulary; therapeutic resource centers; patient assurance program; and diabetes, inflammatory conditions, oncology, and pulmonary solutions. The company was founded in 1986 and is headquartered in St. Louis, MO. | Finance |
CuraScript, Inc.
CuraScript, Inc. Drugstore ChainsRetail Trade CuraScript provided biopharmaceuticals, complex therapies and related disease treatment services. It offered services for physicians, health plan sponsors, and pharmaceutical manufacturers. The company was founded in 1989 and is headquartered in St. Louis, MO. | Retail Trade |
Multiple Sclerosis Society
Multiple Sclerosis Society Miscellaneous Commercial ServicesCommercial Services The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Christine Houston
- Experience